Gc Cell (144510) Fundamentals 2026 — Revenue Analysis | SniperIQ
Gc Cell (144510) is a KR-listed Healthcare company in Biotechnology with a market capitalization of ₩194.8B, trading at ₩12960.00 on the KOE. This SniperIQ fundamentals page covers Gc Cell's valuation, profitability (net margin -149.3%), revenue (₩165.5B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Gc Cell's market cap?
Gc Cell (144510) has a market capitalization of approximately ₩194.8B, trading at ₩12960.00 on the KOE. Market cap moves with the live share price.
What is Gc Cell's P/E ratio?
Gc Cell's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.1x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Gc Cell?
Gc Cell runs a net profit margin of -149.3%, a gross margin of 15.6%, and an operating margin of -8.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Gc Cell generate?
Gc Cell reported revenue of ₩165.5B for fiscal year 2025, with net income of -₩258.9B and earnings per share (EPS) of -17202.54. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Gc Cell pay a dividend?
Gc Cell does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Gc Cell financially healthy?
Gc Cell carries a debt-to-equity ratio of 0.53x and a current ratio of 0.53x, with a market beta of 1.51. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Gc Cell a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Gc Cell (144510) the key facts are: market cap ₩194.8B, revenue ₩165.5B, 52-week range 12340-28450. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Gc Cell's full fundamentals live
Get Gc Cell's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.